Home300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Previous close
¥20.37
Day range
¥19.88 - ¥20.36
Year range
¥18.44 - ¥34.18
Market cap
22.56B CNY
Avg Volume
9.54M
P/E ratio
62.80
Dividend yield
0.89%
Primary exchange
SHE
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 733.90M | -0.45% |
Operating expense | 321.24M | -41.80% |
Net income | 186.62M | 125.81% |
Net profit margin | 25.43 | 126.85% |
Earnings per share | 0.16 | 233.33% |
EBITDA | 378.98M | 5.13% |
Effective tax rate | 7.27% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.05B | -30.93% |
Total assets | 14.72B | 6.23% |
Total liabilities | 5.15B | 12.88% |
Total equity | 9.58B | — |
Shares outstanding | 1.12B | — |
Price to book | 2.37 | — |
Return on assets | 5.68% | — |
Return on capital | 6.93% | — |
Cash Flow
Net change in cash
(CNY) | Sep 2023info | Y/Y change |
---|---|---|
Net income | 186.62M | 125.81% |
Cash from operations | 286.52M | 87.23% |
Cash from investing | -30.03M | 97.85% |
Cash from financing | -169.12K | 99.89% |
Net change in cash | 256.32M | 118.35% |
Free cash flow | -558.41M | 52.76% |
About
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Founded
Sep 8, 1992
Website
Employees
1,902